Singapore markets closed
Straits Times Index
3,306.02 +6.02 (+0.18%) Nikkei
38,596.47 -36.55 (-0.09%) Hang Seng
18,028.52 -306.80 (-1.67%) FTSE 100
8,237.72 -34.74 (-0.42%) Bitcoin USD
64,428.01 +182.68 (+0.28%) CMC Crypto 200
1,352.23 -8.10 (-0.60%)
Cantabio Pharmaceuticals, Inc. (CTBO)
OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
At close: 02:09PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 563.60k |
| Enterprise value | 1.69M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -5.11 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.12 |
| 52-week change 3 | 0.00% |
| S&P500 52-week change 3 | 26.24% |
| 52-week high 3 | 1.0100 |
| 52-week low 3 | 1.0100 |
| 50-day moving average 3 | 1.0100 |
| 200-day moving average 3 | 1.0100 |
Share statistics
| Avg vol (3-month) 3 | N/A |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 22.54k |
| Implied shares outstanding 6 | 558.02k |
| Float 8 | 7.78k |
| % held by insiders 1 | 70.01% |
| % held by institutions 1 | 0.00% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 20 Jun 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:5000 |
| Last split date 3 | 20 Jun 2019 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Mar 2018 |
| Most-recent quarter (mrq) | 31 Dec 2018 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -470.97% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | -1.54M |
| Diluted EPS (ttm) | -8.0800 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 283.37k |
| Total cash per share (mrq) | 12.57 |
| Total debt (mrq) | 1.41M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.15 |
| Book value per share (mrq) | -97.77 |
Cash flow statement
| Operating cash flow (ttm) | -798.4k |
| Levered free cash flow (ttm) | -217.4k |
© 2024 Yahoo. All rights reserved.